PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrCasirivimab and imdevimab for injection Solutions for infusion, each available as 1332 mg/11.1 mL and 300 mg/2.5 mL (120mg/mL) single-use vials Anti-SARS-CoV-2 spike protein monoclonal antibodies HEALTH CANADA HAS AUTHORIZED THE SALE OF THIS COVID-19 DRUG BASED ON …

  Information, Product, Patients, Monographs, Medication, Including, Product monograph including patient, Product monograph including patient medication information

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SPIKEVAX™ Elasomeran mRNA vaccine Dispersion for intramuscular injection Multidose Vial, 100 mcg / 0.5mL Active Immunizing Agent Submission Control Number: 259289 ModernaTX, Inc. 200 Technology Square Cambridge, MA, USA, 02139 Imported and Distributed by: Innomar Strategies, Inc.

  Information, Product, Patients, Monographs, Medication, Including, Product monograph including patient, Product monograph including patient medication information

Pfizer BioNTech COVID-19 Vaccine

comirnaty (covid-19 vaccine, mrna) product monograph page 2 of 53 recent major label changes 1. indications 11/2021 4. dosage and administration 11/2021 7. warnings and precautions 11/2021 table of contents

  Vaccine

Solution for Intramuscular Injection

Each vaccine dose of 0.5 mL is withdrawn into a syringe for injection to be administered intramuscularly, preferably in the deltoid muscle. Use a separate sterile needle and syringe for each individual. Each vial contains at least the number of doses stated. It is normal for liquid to remain in the vial after withdrawing the final dose.

  Syringes

HOW TO PREPARE AND ADMINISTER - COVID-19 vaccines …

4 5 is now the official name of the Pfizer-BioNTech COVID-19 vaccine is now the official name of the Pfizer-BioNTech COVID-19 vaccine HOW TO PREPARE AND ADMINISTER IN AGES 12 AND OLDER – DILUTE BEFORE USE (PURPLE CAP) HOW TO PREPARE AND ADMINISTER IN AGES 12 AND OLDER – DILUTE BEFORE USE (PURPLE CAP) After Dilution1

  Pfizer

COVISHIELD supply (5 mL – 10 doses)

(MgCl2.6H20),Polysorbate 80, EDTA (Edetate Disodium), Ethanol, Water for Injections. Dose: 0.5 ml by Intramuscular injection. Store at 2-8ºC. Keep out of reach of children. DO NOT FREEZE. DO NOT SHAKE. ONCE OPENED, USE WITHIN SIX HOURS. Read pack insert before use. Unused vaccine and waste material must be disposed-off according to local ...

  Date, Disodium, Covishield

COVID-19 Vaccine (ChAdOx1-S [recombinant]),

opaque solution, essentially free from visible particles for intramuscular injection. One dose (0.5 ml) of COVISHIELD contains: COVID-19 Vaccine (ChAdOx1-S * [recombinant]) 5 x 1010 viral particles (not less than 2.5 x 108 infectious units) *Recombinant, replication-deficient chimpanzee adenovirus vector encoding the

  Intramuscular, Covishield

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

concomitant medications during PAXLOVID therapy and monitor for the adverse reactions associated with the concomitant medications (see 2 CONTRAINDICATIONS and 9 DRUG INTERACTIONS). 4 DOSAGE AND ADMINISTRATION PAXLOVID is nirmatrelvir tablets co-packaged with ritonavir tablets. Nirmatrelvir must be co-administered with ritonavir.

  Medication

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

NUVAXOVID is contraindicated in individuals who are hypersensitive to the active ingredient or to any ingredients in the formulation, including any non-medicinal ingredient, or component of the container. (For a complete listing, see DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING). 3 SERIOUS WARNING AND PRECAUTIONS

  Active, Ingredients

How to Bill for Adult Immunizations

“mass immunizers.” For Medicare Part B submissions, physician prac-tices and other mass immunizers must submit a separate preprinted CMS-1500 paper claim form or bill electronically for each type of vaccination (either inZuenza or pneumococcal) and attach a roster bill containing information for two or more Medicare beneYciaries.

  Bill, Immunization, Adults, Immunizer, To bill for adult immunizations

COVID-19 – mRNA Pfizer – Ultra Frozen Vaccine Pediatric 5 ...

Response for immunizers if individual has not consulted with their primary health care provider: “There is limited data on the use of this vaccine in immunocompromised individuals or those with auto-immune disorders. Emerging data has not detected …

  Immunizer

Adverse Event Standard - Alberta Health Services

In Alberta, it is the responsibility of all immunizers who provide provincially and non-provincially-funded vaccines to be aware of possible adverse events following immunization and to follow provincial processes for assessing, reporting and monitoring of AEFI.

  Immunizer

Medicare Claims Processing Manual

10.3 - Simplified Roster Claims for Mass Immunizers 10.3.1 - Roster Claims Submitted to A/B MACs (B) for Mass Immunization 10.3.1.1 - Centralized Billing for Influenza Virus and Pneumococcal Vaccines to A/B MACs (B) 10.3.2 - Claims Submitted to A/B MACs (A) for Mass Immunizations of Influenza Virus and Pneumococcal Vaccinations

  Manual, Medicare, Processing, Claim, Medicare claims processing manual, Immunizer

COMMUNICATION TOOL

Immunization Communication Tool Introduction 2 Introduction The Immunization Communication Tool (ICT) is a project of the Professional Education Working